Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- ;
- RMIT University
- ; University of Southampton
- University of Oslo
- ; University of Warwick
- Academic Europe
- CK-CARE AG
- Christine Kühne – Center for Allergy Research and Education (CK-CARE)
- Heidelberg University
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Leiden University Medical Center (LUMC)
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- iBET - Instituto de Biologia Experimental e Tecnológica
- 12 more »
- « less
-
Field
-
compounds, cancer or immunotherapy research. The candidate should be familiar with air-sensitive chemistry and general analytical techniques such as FTIR, NMR, electrochemistry, etc. Desirable criteria
-
Specific Requirements - You are a highly motivated candidate with an interest in immunotherapy and metabolism. - You have an MSc in Biomedical Sciences, Pharmaceutical Sciences, Biochemistry or a related
-
The project: Research Theme: Infection, Inflammation and Immunotherapy The porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to the global pig industry, causing
-
Main Supervisor: Dr Matthew Blunt Other members of the supervisory team: Dr Andres Vallejo and Professor Salim Khakoo Start date: 23/09/2024 Project description: Immunotherapy offers a kinder and
-
lipids, offering potential tumor biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks
-
such as radio-immunotherapy. Image analysis, programming and use of clinical software’s for treatment planning will be central components of the work. The project will concern both photon and particle
-
dermatitis and throughout the course of immunotherapy. The candidate will apply a variety of cellular, epigenomic and single cell/spatial multiomic approaches and integrate clinical data to advance
-
associated fibroblasts and immune cells) interactions in regulating disease progression and response to various therapies, including oncogene-targeted therapies and immunotherapy (e.g. CJ Hanley et al., Nature
-
, off-the-shelf CD1a/CCR9-directed CAR immunotherapy for relapse/refractory T-cell acute“ ,Ref. 101113067, financed by European Founds. Requirements Research FieldBiological sciences » Biological
-
patients would benefit from additional treatments such as radio-, chemo and/or immunotherapy. A promising new avenue in cancer research involves the use of artificial intelligence for enhanced diagnostics